
Stemcell Transplantation Assisted Reproduction Research Private Limited
Hospital specializing in transplantation and IVF, with various medical specialties available.
Hospital specializing in transplantation and IVF, with various medical specialties available.
Stemcell Transplantation Assisted Reproduction Research Private Limited (STARRPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 March 2016 (Nine years 26 days old ). Its registered office is in Tiruchirappalli, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.20 Cr.
The company currently has active open charges totaling ₹10.07 Cr.
Govindasamy Rajarathinam and Kalaiselvi Rajarathinam serve as directors at the Company.
Tiruchirappalli, Tamil Nadu, India
+91-XXXXXXXXXX
U85100TN2016PTC104490
104490
Private Limited Indian Non-Government Company
02 Mar 2016
30 Sep 2023
31 Mar 2023
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Govindasamy Rajarathinam ![]() | Whole-Time Director | 02-Mar-2016 | Current |
Kalaiselvi Rajarathinam ![]() | Director | 02-Mar-2016 | Current |
Stemcell Transplantation Assisted Reproduction Research Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.89% decrease. The company also saw a substantial improvement in profitability, with a 50.44% increase in profit. The company's net worth Soared by an impressive increase of 85.08%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Stemcell Transplantation Assisted Reproduction Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Govindasamy Rajarathinam and Kalaiselvi Rajarathinam are mutual person
₹10.07 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
26 Oct 2017 | Bank Of India | ₹4.10 M | Open |
27 Sep 2017 | Others | ₹1.74 Cr | Open |
30 Jun 2017 | Others | ₹1.32 Cr | Open |
02 Mar 2017 | Canara Bank | ₹6.60 Cr | Open |
Unlock and access historical data on people associated with Stemcell Transplantation Assisted Reproduction Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Stemcell Transplantation Assisted Reproduction Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stemcell Transplantation Assisted Reproduction Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Stemcell Transplantation Assisted Reproduction Research Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Stemcell Transplantation Assisted Reproduction Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai.
A charge with Canara Bank of Rs. 6.60 Cr registered on 02 Mar 2017 with Charge ID 100126610 was modified on 30 Nov 2021.
A charge with Bank Of India amounted to Rs. 0.41 Cr with Charge ID 100157634 was registered on 26 Oct 2017.
A charge with Others amounted to Rs. 1.74 Cr with Charge ID 100132400 was registered on 27 Sep 2017.
A charge with Others amounted to Rs. 1.32 Cr with Charge ID 100157768 was registered on 30 Jun 2017.
Stemcell Transplantation Assisted Reproduction Research Private Limited was incorporated on 02 Mar 2016.
The authorized share capital of Stemcell Transplantation Assisted Reproduction Research Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 8.20 Cr.
Currently 2 directors are associated with Stemcell Transplantation Assisted Reproduction Research Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Stemcell Transplantation Assisted Reproduction Research Private Limited is Arun Arcade 75A First Cross, North East Extension Road India, Thillainagar, Tamil Nadu, 620018.
The corporate identification number (CIN) of Stemcell Transplantation Assisted Reproduction Research Private Limited is U85100TN2016PTC104490 and the company number is 104490 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Stemcell Transplantation Assisted Reproduction Research Private Limited has fallen by -1.89%.
The financial reports for the fiscal year 2023 indicates that The net worth of Stemcell Transplantation Assisted Reproduction Research Private Limited has experienced an upsurge of 85.08%.
As per the financial statements for fiscal Year 2023, The total open charges for Stemcell Transplantation Assisted Reproduction Research Private Limited amount to ₹ 10.07 Cr.
The most recent Balance Sheet for Stemcell Transplantation Assisted Reproduction Research Private Limited was filed with the ROC on 31 Mar 2023.